Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
for a new investor, NWBO is a golden opportunity to get in after the request for approval has been announced. Then its a matter of counting down the days.
For those invested in NWBO for years, it has been an absolute waste of time other than financing Toucan via Advent.
reality
Personally I will sell if it hits 2$ again, hopefully after MHRA approval
jeez a complete sell off unbelievable
you are 100% accurate PM
LP is consciously conflating the two and in doing so pretending NWBO shareholders are building wealth by financing the build-up of Advent Bioservices Ltd a full subsidiary of Toucan.
In my few LP is in this regard misleading NWBO shareholders
hahahaha lol
Thanks
hahaha thats a typo of course its 62.5 I forgot a DOT pardon me. Its got nothing todo with math
Well lets make a train thought
Lets say the O/S is at 1.7 B and we are being bought for 25B (for sake of argument)
Legally the buying company will then have to pay off management for the 250 million in warrants and options and in this case does it need an ASM to vote yes for the paying off, of management?
If there will never be a paying off, of management then management will have to buy 250 million of common against I think 25 cents? so they need 625 million in cash to buy 250 million in common from the 1.7 A/S prior to the buyout for.. Will there be banks to lend each individual of management that kind of cash? Perhaps. If not then they need to be paid off and if thats the case it may very well be that the BO price must be divided over 1.7B O/S + 250million options/warrants management
Here is a thought to ponder:
The A/S are at 1.7B
The options and warrants for management are at 250 million
The C prefs are 250 million potential common
Does that mean that the buyout will be at 2.2B common shares fully diluted?
what newman described will not happen in the timeframe he described it in of course.
But anything related to a potential future revenue will increase the stock price. Submitting a request for approval does not tell the market there will be revenue, approval itself will.
So the 5$ or over 5 billion market cap is feasible after all approvals are in. Probably not prior to that
The check is large but not that big a deal.
LP said "strategic about filing in multiple places". If that means that NWBO is going to first wait for UK approval. Then reinitiate the CDMO with Cognate Memphis. Then Wait for patients in the US to start demanding DCVAXL because look at the UK medical progress then yes, in that case, its going to be many many years. With that she would risk everything and make patients in the US suffer even more.
There is absolutely no reason not to file for approval with the FDA right after MHRA has been requested MAA. But with NWBO you never know.
anyone who was fantasizing about a BO soon coming to pass has now been confronted with realism, that did not include me. It was never a secret to me Big Pharma would be interested without any RA having approved DCVAXL. Big Pharma cares about approvals which they can make money with and care less about JA.
Your timeline of years of waiting is absurd. LP clearly said that after MIA they will most likely file a request with all RA, not just MHRA. After filing with the FDA the timeline is a year, MHRA 5 months and EMA a year as well which would take us into spring 2024 all RA should be approved. After all RAs have been approved most big pharmas will want to buy NWBO for then the return on investment is derisked via the approvals. I guess the negotiations for approval will take 3-6 months so as I have said here a couple of times already buy out Summer-Fall 2024. So NOT YEARS unless ofcourse Linda needs another year or two to figure out how to mail the request for approval.
LP said it took them 1 year to prepare the application for marketing approval. She said they are now waiting for MIA (which in my view is not necessary to submit but ok).
What I would like to know is what happened to the other 13 months ok 1 year before the started putting the application together?
didnt you know, if you sell NWBO you are a short doesnt matter if prior to that you were holding NWBO stock or after selling NWBO you are a short lol
Fall 2024 after all approvals are in
Thanks because after filing the market can start counting down the days
Me too, but are you talking in past tense. Are you still expecting the MAA to be submitted in Q1?
She said they would submit after MIA is in which in not doubt Q1
what is extremely disappointing is that somehow they are having trouble/challenges readying the request for MAA over the years. Even though she said they are working with consultants.
arggg that was no comment
NWBO/Advent will NOT start producing DCVAX nor have they ever produced for off-label use for other cancer indications outside a medical trial they initiated or without any sort of FDA approval.
It would risk them losing their MIA
end of the story.
Anyone suggesting NWBO will start making loads of money from this urban legend of label story is fooling him/herself and others
ofcourse this discussion has been held here many times and I have said then what I will say now. DCVAX will NOT be used for off-label use for other solid cancer indications in other organs. It just will not. Oncologists will never go off protocol and start experimenting with a non-approved, efficiency-not-proven new drug outside GBM cancer. 98% of cancer patients will follow the oncologists advise.
So, for example, a woman with Triple-Negative Breast Cancer will follow the oncologist's advice an start Trodelvy for treatment and will not go off script with DCVAX. Let alone that Im 99,9% sure Advent/NWBO will refuse to produce DCVAX for a cancer they are currently not conducting a trial in or have been approved in, which they are not at present. NWBO/Advent will throw everything away if they start producing DCVAX for cancers they have not been approved for or not conducting a trial in.
This first part what I said cannot be correct without the second being right. The FDA does not just hand out approvals for drugs for different cancer indications (there are 100 different types) as if were candy on Halloween without evidence of efficiency. They would get sued left and right by big pharma for losing their billion dollar drug currently being the SOC for example bread cancer.
I suggest you study a bit more of how FDA approval process work.
The point that was made is why would NWBO management bother with a lawsuit that may well drag out for years if they know they will be bought in the next 6 months for billions?
It is a sign a company is going to be acquired when management stops defending the stock, well for the first time in NWBOs history NWBO started defending the stock. Also it really IS a nuance for a big pharma if they have the legacy of a trial they could not care a cent about, especially when NWBOs management after the BO is not around anymore. So IF LP is close to a deal with a BP then I'm certain that BP would have advised her NOT to pursue this lawsuit. JMO
agreed. However, ex is not entirely wrong that JVs/partnerships with BP for a minority stake are rare.
I would be very disappointed if NWBO would not be able/not willing to arrange a licensing deal of some sort.